{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:46:58Z","timestamp":1775886418523,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.semarthrit.2016.10.004","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T17:12:58Z","timestamp":1476637978000},"page":"615-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"46","author":[{"given":"Mira","family":"Merashli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose\u2019Delgado","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R.J.","family":"Ames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.10.004_bib1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1365-2133.1975.tb05119.x","article-title":"Arterial thrombosis in scleroderma","volume":"93","author":"Furey","year":"1975","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/0002-8703(88)90463-2","article-title":"Inferior myocardial infarction complicated by mural thrombus and systemic embolization despite anticoagulation in progressive systemic sclerosis with normal coronary arteriograms","volume":"116","author":"Nair","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/ard.49.7.557","article-title":"Axillary vein thrombosis in adolescent onset systemic sclerosis","volume":"49","author":"Leak","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib5","first-page":"685","article-title":"Large vessel arterial thrombosis in systemic sclerosis associated with antiphospholipid antibodies","volume":"17","author":"Shapiro","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib6","first-page":"1598","article-title":"Antiphospholipid syndrome in scleroderma","volume":"20","author":"Whittaker","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"1514","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib8","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: \u3008www.ohri.ca\/programs\/clinical_epidemiology \/ oxford.htm\u3009."},{"key":"10.1016\/j.semarthrit.2016.10.004_bib9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","article-title":"Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events","volume":"26","author":"Bradburn","year":"2007","journal-title":"Statistics in Med"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/0190-9622(90)70198-Q","article-title":"Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis","volume":"23","author":"Katayama","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-774.x","article-title":"Measurement of anticardiolipin antibodies by ELISA using \u03b22-glycoprotein I (\u03b22-GPI) in systemic sclerosis","volume":"105","author":"Ihn","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/ard.61.2.183-a","article-title":"Antibodies to beta2 glycoprotein I and cardiolipin in SSc","volume":"61","author":"Schoenroth","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1136\/ard.2003.016659","article-title":"Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis","volume":"63","author":"Hasegawa","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1136\/ard.2005.038430","article-title":"Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance","volume":"64","author":"Sanna","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib15","first-page":"199","article-title":"Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury","volume":"23","author":"Assous","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib16","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/01.rhu.0000250295.34519.b9","article-title":"Anticardiolipin antibodies in scleroderma","volume":"12","author":"Enzenauer","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib17","first-page":"141","article-title":"Anticardiolipin and anti-\u03b22 glycoprotein-I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis","volume":"158","author":"Marie","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1590\/S0365-05962010000300022","article-title":"Study about the association between anticardiolipin antibodies and peripheral vascular phenomena in patients suffering from systemic scleroderma","volume":"85","author":"Liberati","year":"2010","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08916939508993333","article-title":"Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis","volume":"20","author":"Pucillo","year":"1995","journal-title":"Autoimmunity"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/rheumatology\/40.1.111","article-title":"Antiphospholipid antibody system in systemic sclerosis","volume":"40","author":"Parodi","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/ard.62.6.589","article-title":"More on anticardiolipin and anti-\u03b22 glycoprotein I in systemic sclerosis","volume":"62","author":"Antonioli","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00296-009-1107-0","article-title":"Clinical significance of antiphospholipid antibodies in Indian scleroderma patients","volume":"30","author":"Gupta","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib23","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10067-009-1188-x","article-title":"Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis","volume":"28","author":"Wielosz","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4274\/tjh.2012.0059","article-title":"Antiphospholipid antibodies and systemic scleroderma","volume":"30","author":"Tour\u00e9","year":"2013","journal-title":"Turk J Hematol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.injr.2013.12.002","article-title":"Anticardiolipin antibodies are associated with pulmonary arterial hypertension in Algerian systemic scleroderma patients","volume":"9","author":"Mellal","year":"2014","journal-title":"Indian J Rheumatol"},{"issue":"6 Suppl. 86","key":"10.1016\/j.semarthrit.2016.10.004_bib26","first-page":"S133","article-title":"The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis","volume":"32","author":"Morrisroe","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0248-8663(01)00433-7","article-title":"Pulmonary hypertension screening in systemic sclerosis: Apropos 67 patients","volume":"22","author":"Launay","year":"2001","journal-title":"Rev Med Intern"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/ard.53.8.540","article-title":". Anticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia","volume":"53","author":"Herrick","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib29","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1002\/art.24684","article-title":"Independent association of anti-\u03b22-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients","volume":"60","author":"Boin","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 5","key":"10.1016\/j.semarthrit.2016.10.004_bib30","doi-asserted-by":"publisher","first-page":"v25","DOI":"10.1093\/rheumatology\/ken283","article-title":"Endothelin and scleroderma lung disease","volume":"47","author":"Silver","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/rheumatology\/kei151","article-title":"Levels of F2 isoprostanes in systemic sclerosis: correlation with clinical features","volume":"45","author":"Volpe","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.humpath.2010.05.018","article-title":"Endothelin-1 expression in scleroderma renal crisis","volume":"42","author":"Mouthon","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib33","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/1529-0131(199805)41:5<800::AID-ART5>3.0.CO;2-J","article-title":"Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1","volume":"41","author":"Atsumi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/rheumatology\/kei276","article-title":"Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine","volume":"45","author":"Dooley","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib35","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3899\/jrheum.100494","article-title":"Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome","volume":"37","author":"Ames","year":"2010","journal-title":"J Rheum"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/BOR.0000000000000112","article-title":"Endothelial dysfunction in systemic sclerosis","volume":"26","author":"Altorok","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaut.2009.07.004","article-title":"Patients with antiphospholipid syndrome display endothelial perturbation","volume":"34","author":"Cugno","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1093\/rheumatology\/36.10.1045","article-title":"The coagulation\/fibrinolytic balance in systemic sclerosis. Evidence for a haematological stress syndrome","volume":"36","author":"Ames","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib40","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-0038-1650552","article-title":"Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies. A crucial role for acquired free protein S deficiency","volume":"76","author":"Ames","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1136\/ard.55.2.122","article-title":"Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud\u05f3s phenomenon and systemic sclerosis","volume":"55","author":"Herrick","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1191\/096120300677692516","article-title":"Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies. A pilot study","volume":"9","author":"Ames","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib43","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1194\/jlr.P054569","article-title":"Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies","volume":"56","author":"Tsiantoulas","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib44","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib45","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.10.004_bib46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/0961203309355300","article-title":"Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?","volume":"19","author":"Erkan","year":"2010","journal-title":"Lupus"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017216303456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T10:35:35Z","timestamp":1749638135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216303456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0049017216303456"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.10.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737062713.793568468","asserted-by":"object"}]},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}